Search Result for : Apis

Interview by Himanshu Vatsa | The Dollar Business The Dollar Business (TDB): Apart from nuclear energy and defence sector, what are the areas that have potential to strengthen the business collaboration between India and the United States? Dr. Didar Singh (DDS): In chemical, pharmaceutical, bio-technology and bio-informatics sectors. In R&D, manufacturing and trade in advanced technologies in the fields of conventional munitions, aerospace, electronics, and material sciences. Other emerging sectors with significant market opportunities include lasers, robotics, nano-technology, specialty materials, and advanced design, engineering & construction capabilities. The infrastructure sector which includes ports, airports, roads, highways, power plants, implementation of Smart City projects etc. present an enormous potential for American companies doing business in India. Dr. Didar Singh, Secretary General, FICCI TDB: ...

The Dollar Business Bureau In a move to reduce India’s dependence on imports for bulk drugs and Active Pharmaceutical Ingredient (APIs), the government is making all out efforts to boost the manufacturing in the bulk drugs sector. The government is likely to consider the recommendations made by a high-level committee known as the Katoch Committee. The recommendations by the committee are being examined for formulation of a ‘Policy for Promotion of Manufacturing of Bulk Drugs’, said Hansraj Gangaram Ahir, Minister of State, Ministry of Chemicals and Fertilizers. The Committee, in its suggestions to the Ministry of Chemicals and Fertilizers, has recommended the establishment of the Mega Parks for APIs. For a proper infrastructure, the Committee recommended common facilities such ...